688091 Shanghai Yizhong Pharmaceutical
- 42.00
- +1.73+4.30%
Shanghai Yizhong Pharmaceutical News
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on voluntary disclosure of plans to invest in the construction of a screening and design platform for novel small molecule drugs
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong_2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the 2024 remuneration plan for directors, supervisors and senior management
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on revising and adding some corporate governance systems
Board of Directors Rules of Procedure (April 2024)
Special meeting system for independent directors
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. and its subsidiaries on the use of idle own funds for cash management
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the by-election of independent directors of the second board of directors of the company and the adjustment of the board special committee
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on amending the company's articles of association
Shanghai Yizhong 2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee for the year 2023
Special report of the board of directors on the independent self-inspection of the company's independent directors in 2023
Report on the performance of supervisory duties by the Board of Auditors on accounting firms
Notice of Shanghai Yizhong Pharmaceutical Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the voluntary disclosure of the “Construction of 5 Million Injectable Paclitaxel Polymer Micelles and Supporting Facilities” fund-raising project to obtain construction permits for construction p
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on obtaining the “Pharmaceutical Production License” and the “Notice of Pharmaceutical Production Site Inspection Results from the Shanghai Drug Administration”
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on adjusting the members of the Audit Committee of the 2nd Board of Directors of the Company
Announcement of Resolutions of the Second Extraordinary General Meeting of Shareholders of Shanghai Yizhong Pharmaceutical Co., Ltd. 2023
Shanghai Yizhong_2023 Second Extraordinary General Meeting of Shareholders Meeting Meeting Materials
Analysis
Price Target
No Data
